Showing results (571-580 of 875) with videos related to

Sort By:
Pageof 88
Molecular Psychiatry|July 27, 2016
Functional analysis of rare variants found in schizophrenia implicates a critical role for GIT1-PAK3 signaling in neuroplasticityM J Kim, J Biag, D M Fass, et al.
European Review for Medical and Pharmacological Sciences|February 22, 2023
National trends in suicide-related behaviors among youths between 2005-2020, including COVID-19: a Korean representative survey of one million adolescentsN Kim, J Y Song, H Yang, et al.
Alimentary Pharmacology & Therapeutics|March 2, 2018
Predictors of failure to detect early hepatocellular carcinoma in patients with chronic hepatitis B who received regular surveillanceY E Chon, K S Jung, M-J Kim, et al.
Journal of Neurochemistry|March 31, 1999
Molecular cloning of multiple splicing variants of JIP-1 preferentially expressed in brainI J Kim, K W Lee, B Y Park, et al.
Transplantation Proceedings|April 10, 2012
Hormonal differences between female kidney transplant recipients and healthy women with the same gynecologic conditionsJ M Kim, R K Song, M-J Kim, et al.
The Journal of Biological Chemistry|September 3, 1999
Crystal structure of a maltogenic amylase provides insights into a catalytic versatilityJ S Kim, S S Cha, H J Kim, et al.
Archives of Gerontology and Geriatrics|April 20, 2019
Moderate hearing loss is related with social frailty in a community-dwelling older adults: The Korean Frailty and Aging Cohort Study (KFACS)M Yoo, S Kim, B S Kim, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|August 20, 2015
Pandemic influenza virus, pH1N1, induces asthmatic symptoms via activation of innate lymphoid cellsD H Shim, Y A Park, M J Kim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2009
Phase II study with oxaliplatin and S-1 for patients with metastatic colorectal cancerD Y Zang, B H Lee, H-C Park, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 21, 2019
Capecitabine plus oxaliplatin versus gemcitabine plus oxaliplatin as first-line therapy for advanced biliary tract cancers: a multicenter, open-label, randomized, phase III, noninferiority trialS T Kim, J H Kang, J Lee, et al.
Pageof 88